Tag: Alchemedicine

Asahi Kasei Pharma Strengthens Preclinical Pipeline Through Exclusive Global License Agreement with Alchemedicine for Novel Lead Compounds

27 February 2026 No Comments

TOKYO – February 25, 2026 – Asahi Kasei Pharma announced that it has strengthened

Asahi Kasei Pharma and Alchemedicine advance a novel therapeutic candidate into Phase I study for the treatment of refractory diseases

20 February 2026 No Comments

TOKYO – February 18, 2026 – Asahi Kasei Pharma, a global provider of healthcare